Koers Paxman AB (publ) Nasdaq Stockholm
Aandelen
SE0009806284
Medische apparatuur, benodigdheden & distributie
Omzet 2023 | 210 mln. 19,61 mln. 18,1 mln. | Omzet 2024 * | 292 mln. 27,25 mln. 25,16 mln. | Marktkapitalisatie | 759 mln. 70,79 mln. 65,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | 8 mln. 747K 689K | Nettowinst (verlies) 2024 * | 34 mln. 3,17 mln. 2,93 mln. | EV/omzet 2023 | 3,33 x |
Nettoliquiditeiten 2023 * | 19 mln. 1,77 mln. 1,64 mln. | Nettoliquiditeiten 2024 * | 42 mln. 3,92 mln. 3,62 mln. | EV/omzet 2024 * | 2,45 x |
K/w-verhouding 2023 |
83,6
x | K/w-verhouding 2024 * |
22,2
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 36,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 20-12-16 |
Director of Finance/CFO | 44 | 01-03-20 | |
Patrick Burke
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-01-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 01-12-16 |
Chairman | 70 | 01-12-16 | |
Maria Bech
BRD | Director/Board Member | 56 | 20-12-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,77% | 182 mld. | |
+4,10% | 114 mld. | |
-3,85% | 67,76 mld. | |
+5,19% | 51,91 mld. | |
+5,54% | 43,23 mld. | |
+5,90% | 41,07 mld. | |
+23,81% | 32,07 mld. | |
+16,10% | 25 mld. | |
-5,06% | 24,35 mld. |